Showing results (91-100 of 363) with videos related to
Sort By:
Pageof 37
Dermatologic Clinics|September 15, 2024
Topical Therapy for Atopic Dermatitis: What is New and the New ParadigmMaria Gnarra Buethe, Caitlyn Kellogg, Young Joon Seo, et al.Immunology and Allergy Clinics of North America|July 9, 2026
Topical Therapy for Atopic Dermatitis: What is New and the New ParadigmMaria Gnarra Buethe, Caitlyn Kellogg, Young Joon Seo, et al.Seminars in Cutaneous Medicine and Surgery|September 13, 2017
Atopic dermatitis: emerging therapiesEric Simpson, Jeremy Udkoff, Jenna Borok, et al.Pediatric Dermatology|November 13, 2010
Children with atopic dermatitis appear less likely to be infected with community acquired methicillin-resistant Staphylococcus aureus: the San Diego experienceCatalina Matiz, Wynnis L Tom, Lawrence F Eichenfield, et al.The Journal of Allergy and Clinical Immunology|April 10, 2017
Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelinesLawrence F Eichenfield, Jusleen Ahluwalia, Andrea Waldman, et al.Dermatology and Therapy|October 7, 2024
Efficacy and Safety of Ruxolitinib Cream in Atopic Dermatitis Based on Previous Medication HistoryAndrew Blauvelt, Howard Kallender, Daniel Sturm, et al.Paediatric Drugs|June 13, 2022
Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric SettingLawrence F Eichenfield, Stephen Stripling, Selwyn Fung, et al.Journal of Drugs in Dermatology : JDD|June 4, 2024
Hypothalamic-Pituitary-Adrenal Axis Response in Patients With Acne Vulgaris Treated With ClascoteroneNeal Bhatia, Lawrence F Eichenfield, Alessandro Mazzetti, et al.Seminars in Cutaneous Medicine and Surgery|October 26, 2013
Understanding skin barrier differences: a demographic, cultural, and medical diversity viewpointLawrence F Eichenfield, Peter M Elias, Joseph F Fowler, et al.The Journal of Dermatology|March 14, 2007
Blood concentrations, tolerability and efficacy of pimecrolimus cream 1% in Japanese infants and children with atopic dermatitisLawrence F Eichenfield, Vincent Ho, Janice Matsunaga, et al.Pageof 37